- Home
- NSP vs WGS Comparison
NSP vs WGS Comparison
Compare NSP & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSP
- WGS
- Stock Information
- Founded
- NSP 1986
- WGS 2017
- Country
- NSP United States
- WGS United States
- Employees
- NSP N/A
- WGS N/A
- Industry
- NSP Professional Services
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- NSP Consumer Discretionary
- WGS Technology
- Exchange
- NSP Nasdaq
- WGS Nasdaq
- Market Cap
- NSP 2.4B
- WGS 2.4B
- IPO Year
- NSP 1997
- WGS N/A
- Fundamental
- Price
- NSP $60.37
- WGS $79.83
- Analyst Decision
- NSP Hold
- WGS Strong Buy
- Analyst Count
- NSP 3
- WGS 8
- Target Price
- NSP $80.00
- WGS $89.13
- AVG Volume (30 Days)
- NSP 396.5K
- WGS 716.6K
- Earning Date
- NSP 08-01-2025
- WGS 07-29-2025
- Dividend Yield
- NSP 3.97%
- WGS N/A
- EPS Growth
- NSP N/A
- WGS N/A
- EPS
- NSP 1.65
- WGS N/A
- Revenue
- NSP $6,642,000,000.00
- WGS $330,143,000.00
- Revenue This Year
- NSP $4.83
- WGS $21.91
- Revenue Next Year
- NSP $5.99
- WGS $19.45
- P/E Ratio
- NSP $36.73
- WGS N/A
- Revenue Growth
- NSP 1.90
- WGS 48.81
- 52 Week Low
- NSP $56.36
- WGS $25.32
- 52 Week High
- NSP $104.90
- WGS $117.75
- Technical
- Relative Strength Index (RSI)
- NSP 51.45
- WGS 47.85
- Support Level
- NSP $56.36
- WGS $76.04
- Resistance Level
- NSP $57.99
- WGS $84.35
- Average True Range (ATR)
- NSP 1.55
- WGS 4.16
- MACD
- NSP 0.40
- WGS -0.89
- Stochastic Oscillator
- NSP 67.06
- WGS 21.65
About NSP Insperity Inc.
Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.